Dolutegravir

Name		Dolutegravir
Synonyms		DolutegravirAPI;Dolutegravir(GSK1349572);2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide,N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-,(4R,12aS)-;(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-Chemicalbookpyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamideDolutegravir(GSK1349572);GSK1349572,S-349572,GSK572;(4R,12aS)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;Dolutegravir,>=98%;Dolutegravirfreeacid
Molecular Structure
Molecular Formula		C20H19F2N3O5
Molecular Weight		419.38
CAS Registry Number		1051375-16-6

Handling and storage
Precautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

Specific end use(s): Laboratory chemicals, for scientific research and development only